Add to Calendar 2/12/2019 8:00:00 AM 2/12/2019 10:00:00 AM Gene Therapy Then and Now: Tales of Perseverance From Its Inception to Today We’re on the verge of an innovation breakout. More gene therapies than ever are priming the pipeline and facing approvals, aimed to vastly improve patient lives or even cure their diseases. Join our deep bench of experts for valuable insights and lessons learned from the development of gene therapies. Understand the time and perseverance it takes by all stakeholders to develop truly innovative technologies, from the trials and tribulations that gene therapies have incurred, to what to expect from key advances ahead. For both the scientist and non-scientist alike, you will leave our forum with a deeper respect and perspective of the pioneers who led the way and those now taking the lead to further advance these significant medical therapies. MassBio, 300 Technology Square 8th Fl, Cambridge, MA 02139
Bill was most recently Chief Scientific Officer at CRISPR Therapeutics, establishing the company in the United States through successful financing, IPO and first clinical trial application in Europe. He has held prior senior leadership positions in both large and small bio/pharma companies. He currently serves on several corporate and scientific advisory boards, and is a consultant in the biopharma industry.